CAS: 1488363-78-5

Adomeglivant is a drug that is used in the treatment of metabolic disorders. It is a potent inhibitor of serum alanine aminotransferases and aminotransferases, which are enzymes that catalyze the conversion of amino acids to their corresponding alpha-ketoacids. Adomeglivant has been shown to be effective in diabetic patients with chronic kidney disease by reducing insulin resistance and restoring growth factor levels. This drug also has pharmacokinetic properties that allow it to be taken orally, while also having a natural origin.

Adomeglivant

Adomeglivant (LY2409021) is a potent and selective glucagon receptor antagonist. Which is used in clinical trial for type 2 diabetes mellitus.